Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Hong

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Neurosurgical Review|September 27, 2024
A multicenter study of clinical outcomes and volumetric trends in suspected microprolactinomasChristopher S Hong, Jeremi Chabros, John L Kilgallon, et al.
NPJ Genomic Medicine|June 13, 2020
Persistent <i>STAG2</i> mutation despite multimodal therapy in recurrent pediatric glioblastomaChristopher S Hong, Juan C Vasquez, Adam J Kundishora, et al.
Neurosurgery|June 24, 2024
Assessing Mobility in Patients With Glioblastoma Using Digital Phenotyping-Piloting the Digital Assessment in Neuro-OncologyNoah L A Nawabi, Patrick Emedom-Nnamdi, John L Kilgallon, et al.
Journal of Neurosurgery|June 22, 2023
Portable MRI to assess optic chiasm decompression after endoscopic endonasal resection of sellar and suprasellar lesionsChristopher S Hong, Layton A Lamsam, Vineetha Yadlapalli, et al.
World Neurosurgery|March 11, 2022
Impact of Frailty on Morbidity and Mortality in Adult Patients Undergoing Surgical Evacuation of Acute Traumatic Subdural HematomaAladine A Elsamadicy, Mani Ratnesh S Sandhu, Isaac G Freedman, et al.
Oncotarget|August 29, 2015
TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomasZhen-Yu Zhang, Aden Ka-Yin Chan, Xiao-Jie Ding, et al.
Oncotarget|May 10, 2015
Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapyHui Xu, Shervin Rahimpour, Cody L Nesvick, et al.
Molecular Cancer Therapeutics|May 6, 2015
Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in GlioblastomaIra K Gordon, Jie Lu, Christian A Graves, et al.
Oncotarget|July 1, 2015
Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinomaLai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.
Journal of Neurosurgery|October 27, 2019
Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomasMark W Youngblood, Daniel Duran, Julio D Montejo, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Neurosurgical Review|September 27, 2024
A multicenter study of clinical outcomes and volumetric trends in suspected microprolactinomasChristopher S Hong, Jeremi Chabros, John L Kilgallon, et al.
NPJ Genomic Medicine|June 13, 2020
Persistent <i>STAG2</i> mutation despite multimodal therapy in recurrent pediatric glioblastomaChristopher S Hong, Juan C Vasquez, Adam J Kundishora, et al.
Neurosurgery|June 24, 2024
Assessing Mobility in Patients With Glioblastoma Using Digital Phenotyping-Piloting the Digital Assessment in Neuro-OncologyNoah L A Nawabi, Patrick Emedom-Nnamdi, John L Kilgallon, et al.
Journal of Neurosurgery|June 22, 2023
Portable MRI to assess optic chiasm decompression after endoscopic endonasal resection of sellar and suprasellar lesionsChristopher S Hong, Layton A Lamsam, Vineetha Yadlapalli, et al.
World Neurosurgery|March 11, 2022
Impact of Frailty on Morbidity and Mortality in Adult Patients Undergoing Surgical Evacuation of Acute Traumatic Subdural HematomaAladine A Elsamadicy, Mani Ratnesh S Sandhu, Isaac G Freedman, et al.
Oncotarget|August 29, 2015
TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomasZhen-Yu Zhang, Aden Ka-Yin Chan, Xiao-Jie Ding, et al.
Oncotarget|May 10, 2015
Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapyHui Xu, Shervin Rahimpour, Cody L Nesvick, et al.
Molecular Cancer Therapeutics|May 6, 2015
Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in GlioblastomaIra K Gordon, Jie Lu, Christian A Graves, et al.
Oncotarget|July 1, 2015
Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinomaLai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.
Journal of Neurosurgery|October 27, 2019
Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomasMark W Youngblood, Daniel Duran, Julio D Montejo, et al.
Pageof 10